Literature DB >> 9119811

Interferon-alpha therapy for multiple hemangiomas associated with coarctation of the aorta.

T Hijii1, J Fukushige, K Tasaki, K Ueda.   

Abstract

We report a rare combination of multiple hemangiomas and coarctation of the aorta in a 2-month-old female infant who responded to interferon-alpha (IFN-alpha) therapy. The coarctation was repaired successfully with the use of an artificial graft. In patients with symptomatic hemangiomas that do not respond to steroid therapy, IFN-alpha therapy should be considered.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9119811     DOI： 10.1007/bf02559994

Source DB:  PubMed          Journal:  Heart Vessels        ISSN： 0910-8327            Impact factor:   2.037


  10 in total

Review 1.  Is there an association between hemangioma and syndromes with dysmorphic features?

Authors:  A J Burns; L C Kaplan; J B Mulliken
Journal:  Pediatrics       Date:  1991-12       Impact factor: 7.124

2.  Multiple cutaneous hemangiomas and coarctation of the aorta with right aortic arch.

Authors:  L Vaillant; G Lorette; A Chantepie; M Marchand; D Alison; M C Vaillant; J Laugier
Journal:  Pediatrics       Date:  1988-05       Impact factor: 7.124

Review 3.  Treatment of hemangiomatosis with recombinant interferon alfa.

Authors:  C W White
Journal:  Semin Hematol       Date:  1990-07       Impact factor: 3.851

4.  Management of alarming hemangiomas in infancy: a review of 25 cases.

Authors:  O Enjolras; M C Riche; J J Merland; J P Escande
Journal:  Pediatrics       Date:  1990-04       Impact factor: 7.124

5.  Coarctation of aorta with right aortic arch. Report of surgical correction in 2 cases: one with associated anomalous origin of left circumflex coronary artery from the right pulmonary artery.

Authors:  M Honey; J C Lincoln; M P Osborne; D P de Bono
Journal:  Br Heart J       Date:  1975-09

6.  Coarctation of the aorta with congenital hemangioma of the face and neck and aneurysm or dilatation of a subclavian or innominate artery. A new syndrome?

Authors:  A Schneeweiss; L C Blieden; A Shem-Tov; M Motro; A Feigel; H N Neufeld
Journal:  Chest       Date:  1982-08       Impact factor: 9.410

7.  The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Studies with vascular smooth muscle cells and endothelial cells.

Authors:  A D Heyns; A Eldor; I Vlodavsky; N Kaiser; R Fridman; A Panet
Journal:  Exp Cell Res       Date:  1985-12       Impact factor: 3.905

8.  In vitro characteristics of endothelium from hemangiomas and vascular malformations.

Authors:  J B Mulliken; B R Zetter; J Folkman
Journal:  Surgery       Date:  1982-08       Impact factor: 3.982

9.  Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a.

Authors:  C W White; S J Wolf; D N Korones; H M Sondheimer; M F Tosi; A Yu
Journal:  J Pediatr       Date:  1991-01       Impact factor: 4.406

10.  Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.

Authors:  R A Ezekowitz; J B Mulliken; J Folkman
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.